NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Sudarshan Chemical Q3 FY26: Integration Progresses Amidst Global Demand Headwinds
Sudarshan Chemical reported a challenging Q3 FY26, impacted by weak demand in Europe and North America and significant destocking by customers of the acquired Heubach business. The acquired group saw an EBITDA loss of INR 38 crores, though this was mitigated by INR 40 crores in value capture savings realized during the quarter. Management has initiated a strategic inventory reduction of EUR 30-40 million over the next three quarters to improve cash flow and reduce debt, despite a projected temporary EBITDA hit of EUR 9-12 million. The company maintains a stable net debt-to-equity ratio of 0.5, with a 9-month EPS standing at negative INR 1.4.
முக்கிய அம்சங்கள்
Realized INR 40 crores in value capture savings in Q3 FY26 compared to Q1.Acquired Heubach business reported an EBITDA loss of INR 38 crores for the quarter.Strategic plan to reduce inventory by EUR 30-40 million to boost operating cash flow.Anticipated temporary reduction in reported EBITDA by EUR 9-12 million due to inventory rationalization.Net debt-to-equity ratio remains healthy at 0.5 despite global macro challenges.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's ability to execute the Heubach integration and monitor the transition from reported EBITDA losses to improved cash flow through inventory reduction. The 'WATCH' status is advised until the temporary margin compression from inventory rationalization stabilizes.
Sudarshan Chemical Q3 PAT at ₹22.5 Cr; Revenue Dips 4.3% YoY to ₹550.3 Cr
Sudarshan Chemical reported a mixed performance for Q3 FY26, with revenue declining 4.3% YoY to ₹550.3 crore. Net profit stood at ₹22.5 crore, which was significantly impacted by a one-time exceptional charge of ₹26.5 crore due to the statutory impact of new Labour Codes on gratuity. On a positive note, the nine-month PAT for FY26 showed strong growth at ₹169.9 crore compared to ₹118.6 crore in the previous year. The company also renewed a €6 million corporate guarantee for its European subsidiary to support working capital needs.
முக்கிய அம்சங்கள்
Revenue from operations fell to ₹550.3 crore in Q3 FY26 from ₹574.8 crore in Q3 FY25.Net Profit for the quarter was ₹22.5 crore, including a ₹26.5 crore exceptional hit from new Labour Code provisions.Nine-month PAT increased by 43% YoY to ₹169.9 crore despite a drop in total nine-month revenue to ₹1,664 crore.Board approved renewal of a €6 million corporate guarantee for wholly-owned subsidiary Sudarshan Europe B.V.Finance costs decreased to ₹5.7 crore in Q3 FY26 from ₹9.1 crore in the same quarter last year.
👀 கவனிக்க வேண்டியவை
Investors should look past the one-time exceptional labor cost hit and focus on the improving nine-month profitability margins. Monitor the successful integration of the Heubach Group acquisition and global pigment demand recovery for long-term growth.
Sudarshan Chemical Q3 FY26: Revenue at ₹2,103 Cr; Heubach Integration Impacts Margins
Sudarshan Chemical reported a consolidated revenue of ₹2,103 Cr for Q3 FY26, largely driven by the acquisition of the Heubach group. While the legacy business contributed ₹712 Cr, the acquired group faced a ₹38 Cr adjusted EBITDA loss due to global demand softness and destocking. Management has revised the FY26 Business EBITDA guidance for the acquired group downward to €16 Mn from €25 Mn. However, the company achieved ₹40 Cr in fixed cost savings during the quarter as part of its integration value capture plan.
முக்கிய அம்சங்கள்
Consolidated Q3 FY26 Revenue reached ₹2,103 Cr, with the Acquired Group contributing ₹1,479 Cr.One Sudarshan Consolidated Adjusted EBITDA margin stood at 1.9% for Q3, impacted by losses in the acquired entity.Achieved ₹40 Cr in fixed cost savings in Q3 FY26 through organizational optimization and the new Global Capability Center.Revised FY26 Business EBITDA outlook for the Acquired Group to ~€16 Mn, down from the previous €25 Mn guidance.Net Debt stood at ₹1,123 Cr as of December 2025, with a Net Debt to Equity ratio of 0.5.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the integration progress and the realization of the €90-100 Mn EBITDA target by FY29. Short-term volatility is expected as the company rationalizes inventory and navigates low global demand in the coatings and plastics segments.
Sudarshan Chemical Q3 PAT at ₹22.5 Cr; Renews €6 Million Guarantee for European Subsidiary
Sudarshan Chemical reported a standalone Net Profit of ₹22.5 crore for Q3 FY26, a significant drop from ₹74.1 crore in the previous quarter, largely due to a ₹26.5 crore exceptional charge related to new Labour Codes. Revenue from operations for the quarter stood at ₹550.3 crore, compared to ₹582.5 crore in Q2 FY26. The Board also approved the renewal of a €6 million corporate guarantee for its wholly-owned subsidiary, Sudarshan Europe B.V., to secure working capital facilities. This follows the company's major global expansion via the Heubach Group acquisition completed in March 2025.
முக்கிய அம்சங்கள்
Standalone Revenue from operations reached ₹550.3 crore in Q3 FY26, down 5.5% QoQ.Net Profit impacted by a ₹26.5 crore exceptional item due to statutory changes in Labour Codes (gratuity impact).Board approved renewal of a €6 million Corporate Guarantee for Sudarshan Europe B.V. for working capital needs.Nine-month standalone PAT stands at ₹169.9 crore, showing growth over ₹118.6 crore in the previous year's corresponding period.Company confirmed full utilization of ₹800 crore QIP proceeds for the Heubach Group acquisition and debt repayment.
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin recovery in upcoming quarters as the one-time impact of the Labour Code adjustments subsides. The successful integration and performance of the newly acquired Heubach Group assets remain the primary long-term value driver.
Sudarshan Chemical Receives GST Demand Order of Rs 50.58 Crore for FY 2021-22
Sudarshan Chemical Industries Limited has received a GST demand order (DRC-07) from the Deputy Commissioner of State Tax, Maharashtra, for the financial year 2021-22. The total demand amounts to Rs. 50.58 Crores, comprising tax, interest, and penalties. The company has stated that it intends to file an appeal against this order and believes it has a strong case on all points raised. Management currently anticipates no immediate impact on the company's financial or operational activities.
முக்கிய அம்சங்கள்
Total GST demand of Rs. 50,58,05,808 issued for the period April 2021 to March 2022.The demand includes Tax of Rs. 26.91 Crores, Interest of Rs. 20.98 Crores, and a Penalty of Rs. 2.69 Crores.Order passed by the Office of Deputy Commissioner of State Tax, Bhosari-513, Maharashtra.Company is in the process of filing an appeal before the appropriate authority to contest the order.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the appeal process as the demand amount is significant, though the company is confident in its legal position. No immediate change in investment thesis is required pending further legal developments.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Sudarshan Chemical Shareholders Approve Appointment of Four Directors via Postal Ballot
Sudarshan Chemical Industries Limited has successfully passed four resolutions via postal ballot for the appointment of new directors. Shareholders approved the appointment of Apurva Chandra and Rajendra Mariwala as Independent Directors for five-year terms with over 99% support. Additionally, Amitabha Mukhopadhyay and Sanjay K. Asher were appointed as Non-Executive Non-Independent Directors, receiving 93.01% and 95.88% approval respectively. While all resolutions passed with the requisite majority, institutional investors showed some resistance to the non-independent appointments, with up to 17.77% voting against Mr. Mukhopadhyay.
முக்கிய அம்சங்கள்
Apurva Chandra and Rajendra Mariwala appointed as Independent Directors for 5-year terms with over 99% approval.Amitabha Mukhopadhyay appointed as Non-Executive Director with 93.01% favour; 17.77% of institutional votes were against.Sanjay K. Asher appointed as Non-Executive Director with 95.88% favour; 10.47% of institutional votes were against.Total voting turnout was 78.06% of the 78.6 million shares held by 61,236 shareholders on the record date.
👀 கவனிக்க வேண்டியவை
Investors should view these appointments as a routine strengthening of the board's governance and oversight. No immediate action is required as the resolutions were passed with comfortable majorities, ensuring management continuity.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
